302 participants
S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-08-04
- Start Date:
- 2021-09-01
- Completion:
- 2024-08-01
Conditions
- Locally Advanced Gastroesophageal Junction Adenocarcinoma
- Chemotherapy Effect
Interventions
- DRUG
No Results Yet